CONMED Corporation
General ticker "CNMD" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $1.8B (TTM average)
CONMED Corporation does not follow the US Stock Market performance with the rate: -4.5%.
Estimated limits based on current volatility of 1.4%: low 44.00$, high 45.28$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-09-15, amount 0.20$ (Y0.45%)
- Total employees count: 3900 as of 2024
- US accounted for 16.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Supply chain disruptions, Pandemic risks, Regulatory and compliance, Cybersecurity threats, Product development and market acceptance
- Current price 20.5% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [55.67$, 87.72$]
- 2025-12-31 to 2026-12-31 estimated range: [55.36$, 87.91$]
Financial Metrics affecting the CNMD estimates:
- Negative: with PPE of 16.7 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 15.33
- Negative: negative Industry operating cash flow (median)
- Positive: 6.82 < Operating cash flow per share per price, % of 7.77
- Positive: Investing cash flow per share per price, % of -0.61 > -0.66
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.43
- Positive: 18.93 < Shareholder equity ratio, % of 41.74 <= 41.86
- Positive: Inventory ratio change, % of 0.60 <= 0.84
Short-term CNMD quotes
Long-term CNMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,045.47MM | $1,244.74MM | $1,307.02MM |
| Operating Expenses | $975.42MM | $1,124.14MM | $1,106.69MM |
| Operating Income | $70.05MM | $120.60MM | $200.33MM |
| Non-Operating Income | $-140.92MM | $-39.77MM | $-37.30MM |
| Interest Expense | $28.91MM | $39.77MM | $37.30MM |
| R&D Expense | $47.15MM | $52.60MM | $54.43MM |
| Income(Loss) | $-70.86MM | $80.83MM | $163.03MM |
| Taxes | $9.72MM | $16.37MM | $30.61MM |
| Profit(Loss)* | $-80.58MM | $64.46MM | $132.42MM |
| Stockholders Equity | $745.54MM | $834.22MM | $962.68MM |
| Inventory | $332.32MM | $318.32MM | $346.72MM |
| Assets | $2,297.59MM | $2,300.02MM | $2,306.25MM |
| Operating Cash Flow | $33.37MM | $125.35MM | $166.97MM |
| Capital expenditure | $21.79MM | $19.03MM | $13.08MM |
| Investing Cash Flow | $-249.53MM | $-20.03MM | $-13.08MM |
| Financing Cash Flow | $225.00MM | $-110.43MM | $-151.00MM |
| Earnings Per Share** | $-2.68 | $2.10 | $4.29 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.